Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

ClinicalTrials.gov ID: NCT02014896

Public ClinicalTrials.gov record NCT02014896. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The proposed study will validate the clinical use of new biomarker blood tests to identify blood components that may differentiate between diverse stroke etiologies and clinical outcomes as listed below: 1. Differentiate between cardioembolic and large artery atherosclerotic ischemic strokes, when hemorrhagic stroke is ruled out. 2. In cases of ischemic strokes of unknown or "cryptogenic" etiology, determine the ability of biomarker blood tests to predict etiology between cardioembolic and large artery atherosclerotic. 3. In cases of cardioembolic ischemic stroke, further differentiation of cardioembolic ischemic strokes into those caused by atrial fibrillation (AF) and those not caused by AF. 4. Differentiate "transient ischemic attacks" (TIAs) from acute ischemic strokes. 5. Differentiate TIAs from non-ischemic "transient neurological events" (TNE) with similar symptoms.

Study identification

NCT ID
NCT02014896
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Ischemia Care LLC
Industry
Enrollment
1,750 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2013
Primary completion
Oct 31, 2019
Completion
Dec 31, 2019
Last update posted
Jul 7, 2020

2013 – 2020

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Dignity Health Mercury San Juan Sacramento California 95816
Zuckerberg San Francisco General Hospital (UCSF) San Francisco California 94110
University of California San Francisco Medical Center Hospital San Francisco California 94143
Henry Ford Hospital Detroit Michigan 48202
William Beaumont Hospital - Beaumont Health System Royal Oak Michigan 48073
Washington University, University Hospital in St Louis St Louis Missouri 63110
The Stroke Center at Saint Barnabas Medical Center Livingston New Jersey 07039
Montefiore Medical Center (University Hospital for Albert Einstein College of Medicine) The Bronx New York 10467
University of North Carolina Department of Neurology - Stroke Division Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Wake Forest School of Medicine Winston-Salem North Carolina 27157
Cleveland Clinic Cleveland Ohio 44195
Riverside Methodist Hospital/ Ohio Health Research Institute Columbus Ohio 43214
Kettering Medical Center Kettering Ohio 45429
Genesis Healthcare System Zanesville Ohio 43701
Providence Health and Services Portland Oregon 97225
University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Medical University of South Carolina Charleston South Carolina 29425
Chattanooga Center for Neurologic Research Chattanooga Tennessee 37403
Baylor College of Medicine Houston Texas 77030
UT Health Department of Neurology Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02014896, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2020 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02014896 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →